Five Prime Therapeutics, Inc. Engages FLG Partners

April 13, 2018 – Five Prime Therapeutics, Inc. (NASDAQ: FPRX) announced today that FLG partner Linda Rubinstein has been engaged as interim Chief Financial Officer. Company Form 8-K.

Read More
DigiSight Technologies Inc. Form Collaboration With American Academy of Opthalmology

The American Academy of Ophthalmology and FLG client, DigiSight Technologies, Inc. have announced a collaboration agreement to operate the world’s largest database of ophthalmic clinical information. As part of the agreement, the Academy is licensing commercial application of its IRIS® Registry (Intelligent Research in Sight) to DigiSight. FLG’s Jonathan Wolter has been CFO…Read More

Read More
Cantaloupe Systems is Acquired by USA Technologies, Inc.

November 7, 2017 – Former FLG client Cantaloupe Systems announced it is being acquired by USA Technologies, Inc. (NASDAQ : USAT). Company press release. FLG partners: Eric Hall and Frank Tsai.

Read More
biOasis Technologies Engages FLG Partners

October 2, 2017 – VANCOUVER, BC, BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a biopharmaceutical company focused on overcoming the limitations of therapeutic drug delivery across the blood-brain barrier (BBB) and into the central nervous system for the treatment of neurological diseases and disorders, today announced the appointment of Christopher P. Lowe, M.B.A., as…Read More

Read More
Soleno Therapeutics Engages FLG Partners

September 5, 2017 – Soleno Therapeutics Inc. (NASDAQ CM: SLNO) announced today that it has engaged FLG Partners for interim CFO services. Company Form 8-K. FLG partner: Jonathan Wolter.

Read More